Hirasawa Y, Kubota Y, Mura E, Suzuki R, et al. Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment. Anticancer Res 2024;44:3397-3407.
PMID: 39060084